189 related articles for article (PubMed ID: 32199549)
1. Correlates of death during outpatient treatment for opioid use disorder: A national study.
Goldman JE; Samuels EA; Rich JD; Marshall BDL
J Subst Abuse Treat; 2020 May; 112():76-85. PubMed ID: 32199549
[TBL] [Abstract][Full Text] [Related]
2. National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness.
Han BH; Doran KM; Krawczyk N
J Subst Abuse Treat; 2022 Jan; 132():108504. PubMed ID: 34102461
[TBL] [Abstract][Full Text] [Related]
3. The impact of psychiatric comorbidity on treatment discontinuation among individuals receiving medications for opioid use disorder.
Friesen EL; Kurdyak P
Drug Alcohol Depend; 2020 Nov; 216():108244. PubMed ID: 32861134
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with receipt of medication for opioid use disorder among pregnant individuals entering treatment programs in the U.S.
Curran L; Manuel J
Int J Drug Policy; 2024 Apr; 126():104342. PubMed ID: 38479161
[TBL] [Abstract][Full Text] [Related]
5. Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019.
Mauro PM; Gutkind S; Annunziato EM; Samples H
JAMA Netw Open; 2022 Mar; 5(3):e223821. PubMed ID: 35319762
[TBL] [Abstract][Full Text] [Related]
6. Association between availability of medications for opioid use disorder in specialty treatment and use of medications among patients: A state-level trends analysis.
Solomon KT; Bandara S; Reynolds IS; Krawczyk N; Saloner B; Stuart E; Connolly E
J Subst Abuse Treat; 2022 Jan; 132():108424. PubMed ID: 34144299
[TBL] [Abstract][Full Text] [Related]
7. Association of Receipt of Opioid Use Disorder-Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
Jones CM; Shoff C; Blanco C; Losby JL; Ling SM; Compton WM
JAMA Psychiatry; 2023 May; 80(5):508-514. PubMed ID: 36988913
[TBL] [Abstract][Full Text] [Related]
8. Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults.
Welsh JW; Dennis ML; Funk R; Mataczynski MJ; Godley MD
J Subst Abuse Treat; 2022 Jan; 132():108584. PubMed ID: 34391589
[TBL] [Abstract][Full Text] [Related]
9. A National Study of Homelessness, Social Determinants of Health, and Treatment Engagement Among Outpatient Medication for Opioid Use Disorder-Seeking Individuals in the United States.
Gaeta Gazzola M; Carmichael ID; Christian NJ; Zheng X; Madden LM; Barry DT
Subst Abus; 2023; 44(1):62-72. PubMed ID: 37226909
[TBL] [Abstract][Full Text] [Related]
10. Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings.
Krawczyk N; Williams AR; Saloner B; Cerdá M
J Subst Abuse Treat; 2021 Jul; 126():108329. PubMed ID: 34116820
[TBL] [Abstract][Full Text] [Related]
11. Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.
Rogal S; Youk A; Agbalajobi O; Zhang H; Gellad W; Fine MJ; Belperio P; Morgan T; Good CB; Kraemer K
Am J Gastroenterol; 2021 Jul; 116(7):1406-1413. PubMed ID: 33811202
[TBL] [Abstract][Full Text] [Related]
12. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
[TBL] [Abstract][Full Text] [Related]
13. The cost of opioid use disorder-related conditions in Medicare.
Mark TL; Parish WJ; Weber EM; Steinberg DG; Henretty K
Drug Alcohol Depend; 2023 Mar; 244():109778. PubMed ID: 36701935
[TBL] [Abstract][Full Text] [Related]
14. Medication for opioid use disorder treatment and specialty outpatient substance use treatment outcomes: Differences in retention and completion among opioid-related discharges in 2016.
Askari MS; Martins SS; Mauro PM
J Subst Abuse Treat; 2020 Jul; 114():108028. PubMed ID: 32527510
[TBL] [Abstract][Full Text] [Related]
15. Differential adoption of opioid agonist treatments in detoxification and outpatient settings.
Dunn KE; Huhn AS; Strain EC
J Subst Abuse Treat; 2019 Dec; 107():24-28. PubMed ID: 31757261
[TBL] [Abstract][Full Text] [Related]
16. The cascade of care for opioid use disorder among youth in British Columbia, 2018.
Krebs E; Min JE; Zhou H; Davison C; McGowan G; Nosyk B
J Subst Abuse Treat; 2021 Nov; 130():108404. PubMed ID: 34118696
[TBL] [Abstract][Full Text] [Related]
17. National outpatient medication utilization for opioid and alcohol use disorders from 2014 to 2016.
Evoy KE; Roccograndi L; Le S; Leonard CE; Covvey JR; Ochs L; Peckham AM; Soprano SE; Reveles KR
J Subst Abuse Treat; 2020 Dec; 119():108141. PubMed ID: 33138926
[TBL] [Abstract][Full Text] [Related]
18. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
[TBL] [Abstract][Full Text] [Related]
19. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.
Gordon AJ; Drexler K; Hawkins EJ; Burden J; Codell NK; Mhatre-Owens A; Dungan MT; Hagedorn H
Subst Abus; 2020; 41(3):275-282. PubMed ID: 32697170
[TBL] [Abstract][Full Text] [Related]
20. Outpatient care for opioid use disorder among the commercially insured: Use of medication and psychosocial treatment.
Busch AB; Greenfield SF; Reif S; Normand ST; Huskamp HA
J Subst Abuse Treat; 2020 Aug; 115():108040. PubMed ID: 32600627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
